1. A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management. (2nd January 2020) Authors: Grine, L.; de la Brassinne, M.; Ghislain, P.‐D.; Hillary, T.; Lambert, J.; Segaert, S.; Willaert, F.; Lambert, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 4(2020) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam. (28th March 2019) Authors: Jalili, A.; Lebwohl, M.; Stein Gold, L.; Andersen, S.B.; Jensen, K.L.; Pink, A.E.; Segaert, S.; Berg, P.; Calzavara‐Pinton, P.G.; de la Cueva Dobao, P.; Thaçi, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 4(2019) Page Start: 709 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1). (31st July 2020) Authors: Lambert, J.L.W.; Segaert, S.; Ghislain, P.D.; Hillary, T.; Nikkels, A.; Willaert, F.; Lambert, J.; Speeckaert, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 8(2020) Page Start: 1654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2). (13th August 2020) Authors: Lambert, J.L.W.; Segaert, S.; Ghislain, P.D.; Hillary, T.; Nikkels, A.; Willaert, F.; Lambert, J.; Speeckaert, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: 1914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Quality of life and patient‐perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed‐dose combination Cal/BD foam: A post‐hoc analysis of PSO‐LONG. (21st October 2021) Authors: Jalili, A.; Calzavara‐Pinton, P.; Kircik, L.; Lons‐Danic, D.; Pink, A.; Tyring, S.; de la Cueva, P.; Gooderham, M.; Segaert, S.; Nyholm, N.; Thoning, H.; Petersen, B.; Thaçi, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 1(2022) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease. (27th March 2019) Authors: Pink, A.E.; Jalili, A.; Berg, P.; Calzavara‐Pinton, P.G.; de la Cueva Dobao, P.; Thaçi, D.; Torpet, M.; Jensen, K.L.; Segaert, S. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 6(2019) Page Start: 1116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reformulations of well‐known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients. (22nd May 2017) Authors: Iversen, L.; Dauden, E.; Segaert, S.; Freeman, K.; Magina, S.; Rigopoulos, D.; Thaci, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 8(2017) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗